After two years of heightened alerts, the U.S. Centers for Disease Control and Prevention (CDC) says the timing of seasonal respiratory syncytial virus (RSV) cases was disrupted during the COVID-19 pandemic.
The CDC's Morbidity and Mortality Weekly Report, published on April 7, 2023, stated RSV circulation was historically low during 2020–21.
And began earlier and continued longer during 2021–22 than previous RSV seasons.
And the 2022–23 RSV season started later than 2021–22, suggesting a return toward prepandemic seasonality.
RSV Season Returns to Normal
Anakinra Does Not Prevent Mechanical Ventilation in Severe COVID-19 Pneumonia
However, authors say anakinra may have a role as early treatment for patients with less severe COVID-19
Hereditary Angioedema Remains Challenge to Diagnose, Treat
Respondents cite economic issues related to treatment, which can be compounded for patients living in rural areas
Ursodeoxycholic Acid Cuts SARS-CoV-2 Infection, Severity
UDCA exposure among participants with cirrhosis tied to reduced odds of developing SARS-CoV-2 infection